Sign In
Buy ASND
$243.91
-7.16 (-2.85%)
At Close: Jul 31, 2026
The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive
12:00am, Thursday, 21'st May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs on May 20.)
ADC Therapeutics SA (...
Ascendis Pharma A/S Reports First Quarter 2020 Financial Results
08:01pm, Tuesday, 19'th May 2020
– On track for filing U.S. Biologics License Application for TransCon hGH in second quarter, and advancing Marketing Authorisation Application in Europe to third quarter – –.
Ascendis Pharma A/S to Host Earnings Call
06:30pm, Tuesday, 19'th May 2020
NEW YORK, NY / ACCESSWIRE / May 19, 2020 / Ascendis Pharma A/S (NASDAQ:ASND) will be discussing their earnings results in their 2020 First Quarter Earnings call to be held on May 19, 2020 at 4:30 PM E
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 18)
ADC Therapeutics SA (NYSE:...
The Week Ahead In Biotech: Aquestive Awaits FDA Decision, Earnings Flow Slows
12:00am, Sunday, 17'th May 2020
Biotech stocks had another up week, with the American Society of Gene & Stem Cell Therapy virtual conference presentations and the ASCO abstracts made available online ...
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
12:00am, Wednesday, 13'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 12)
Acceleron Pharma Inc (NASDAQ...
Ascendis Pharma A/S Will Appoint Jesper Høiland as Global Chief Commercial Officer
12:30pm, Monday, 11'th May 2020
Ascendis Pharma A/S (ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical needs, today announced that the company will appoint Jesper Høil
7 “Strong Buy” Healthcare Stocks to Buy Now
03:46pm, Friday, 08'th May 2020
As the month of May kicked off, stocks got off to a rocky start. The market slumped in response to a first quarter profit miss from eCommerce giant Amazon (NASDAQ:AMZN) and its plan to put all second-
Ascendis Pharma A/S Announces First Quarter 2020 Financial Results and Business Update Conference Call on May 19
08:01pm, Thursday, 07'th May 2020
Ascendis Pharma A/S (ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical needs, today announced that the company will hold a conference ca
BioMarin Pharmaceutical (BMRN) Receives a Buy from Canaccord Genuity
10:12am, Friday, 01'st May 2020
In a report issued on April 27, Michelle Gilson from Canaccord Genuity maintained a Buy rating on BioMarin Pharmaceutical (BMRN), with a price target of
BioMarin Pharmaceutical (BMRN) Receives a Buy from Canaccord Genuity
10:12am, Friday, 01'st May 2020
In a report issued on April 27,
Michelle Gilson
from Canaccord Genuity maintained a
Buy
rating on BioMarin Pharmaceutical (
BMRN
–
Research Report
), with a price target of
$108.00
. The company’s
Analysts Offer Insights on Healthcare Companies: SLANG Worldwide (OtherSLGWF), Stryker (SYK) and BioMarin Pharmaceutical (BMRN)
10:07am, Friday, 01'st May 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on SLANG Worldwide (SLGWF), Stryker (SYK) and BioMarin
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on SLANG Worldwide
Ascendis Pharma A/S (NASDAQ:ASND) Lowered to Hold at BidaskClub
08:54am, Tuesday, 28'th Apr 2020
Ascendis Pharma A/S (NASDAQ:ASND) was downgraded by stock analysts at BidaskClub from a “buy” rating to a “hold” rating in a research note issued on Tuesday, BidAskClub reports. Several other
Best & Worst ADRs - Monday, April 27
04:04pm, Monday, 27'th Apr 2020
The top-ranked sectors are healthcare, technology, consumer goods, and utilities.
